RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      AI시대에 디지털 의료기기의 법적 문제 ― 디지털의료제품법을 중심으로 ― = Legal Issues of Digital Medical Devices in the AI ​​Era - Focusing on the Digital Medical Products Act -

      한글로보기

      https://www.riss.kr/link?id=A109606701

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The COVID-19 pandemic has brought about tremendous changes to our medical environment. As face-to-face treatment centered on doctors and patients became difficult, non-face-to-face treatment became necessary. Telephone treatment was temporarily allowed starting in February 2020, and even after the end of COVID-19, voices demanding permission for non-face-to-face treatment continued.
      Recently, interest in digital healthcare has expanded due to various changes in the situation, and a certain level of consensus has been formed on the need to establish a new medical system. Interest in digital healthcare has greatly increased along with the development of information and communication technologies such as AI, big data, cloud, and wearables. However, in the current medical law system that is hardware-centered and optimized for traditional medicine, there are limitations in accepting innovations in digital technology centered on software, medical data, and networks and efficiently evaluating the safety and efficacy of continuously developing digital medical devices. In addition, as the development of medical devices, pharmaceuticals, and various new products related to them has expanded in the large category of healthcare, laws have become necessary to enhance the reliability of these products and support safety regulations. In January 2024, the ‘Digital Medical Products Act’ was enacted. The Digital Medical Products Act, which will be implemented from January 2025, introduces a full-cycle regulatory system in Korea, including clinical trials, approvals, and distribution management, tailored to the characteristics of medical products that use AI and network connection technology. I believe that the enactment of this law was possible because of the government’s will to lead the regulation of AI and digital medical products, and on the other hand, there was a demand for the introduction of a new system for the development of digital healthcare in a changing medical environment. However, various problems may arise during the implementation process of the law, and I believe that trial and error can be reduced through legal discussions on these issues.
      번역하기

      The COVID-19 pandemic has brought about tremendous changes to our medical environment. As face-to-face treatment centered on doctors and patients became difficult, non-face-to-face treatment became necessary. Telephone treatment was temporarily allowe...

      The COVID-19 pandemic has brought about tremendous changes to our medical environment. As face-to-face treatment centered on doctors and patients became difficult, non-face-to-face treatment became necessary. Telephone treatment was temporarily allowed starting in February 2020, and even after the end of COVID-19, voices demanding permission for non-face-to-face treatment continued.
      Recently, interest in digital healthcare has expanded due to various changes in the situation, and a certain level of consensus has been formed on the need to establish a new medical system. Interest in digital healthcare has greatly increased along with the development of information and communication technologies such as AI, big data, cloud, and wearables. However, in the current medical law system that is hardware-centered and optimized for traditional medicine, there are limitations in accepting innovations in digital technology centered on software, medical data, and networks and efficiently evaluating the safety and efficacy of continuously developing digital medical devices. In addition, as the development of medical devices, pharmaceuticals, and various new products related to them has expanded in the large category of healthcare, laws have become necessary to enhance the reliability of these products and support safety regulations. In January 2024, the ‘Digital Medical Products Act’ was enacted. The Digital Medical Products Act, which will be implemented from January 2025, introduces a full-cycle regulatory system in Korea, including clinical trials, approvals, and distribution management, tailored to the characteristics of medical products that use AI and network connection technology. I believe that the enactment of this law was possible because of the government’s will to lead the regulation of AI and digital medical products, and on the other hand, there was a demand for the introduction of a new system for the development of digital healthcare in a changing medical environment. However, various problems may arise during the implementation process of the law, and I believe that trial and error can be reduced through legal discussions on these issues.

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼